€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
Loading market information…
MIL · EUK.MI · EUR
Stock price, earnings
Quote as of Oct 28, 2026, 05:55 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
EuKedos S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 38.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow EuKedos S.p.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
$20.24+$0.81 (+4.17%)
Stevanato Group S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 25.04% below the high.
€80.60-€1.16 (-1.42%)
DiaSorin S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.07% below the high.
€10.43+€0.35 (+3.47%)
Emeis’s quoted price sits in the lower half of its reported 52-week range, 34.81% below the high.
€3.36+€0.11 (+3.38%)
Clariane SE’s quoted price sits in the lower half of its reported 52-week range, 24.05% below the high.
€8.84-€0.10 (-1.12%)
Ramsay Générale de Santé S.A.’s quoted price sits in the lower half of its reported 52-week range, 23.46% below the high.
€24.10+€0.20 (+0.84%)
LNA Santé S.A.’s quoted price sits in the lower half of its reported 52-week range, 33.97% below the high.
€0.02+€0.00 (+0.49%)
Risanamento S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 60.19% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
